Showing results (511-520 of 921) with videos related to

Sort By:
Pageof 93
Journal of Substance Abuse Treatment|January 5, 2002
The impact of impulsivity on cocaine use and retention in treatmentF G Moeller, D M Dougherty, E S Barratt, et al.
ACS Biomaterials Science & Engineering|August 26, 2025
Development of GelMA-Based Hydrogel Scaffolds with Tunable Mechanical Properties for Applications in Peripheral Nerve RegenerationKylie M Schmitz, Tanner L Larson, Michael W Borovich, et al.
Cancer Research|April 15, 2000
Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patientsJ Rohayem, P Diestelkoetter, B Weigle, et al.
Breast (Edinburgh, Scotland)|February 27, 2009
Chest wall resection for internal mammary lymph node metastases of breast cancerAlbertus N van Geel, Michel W Wouters, Carmen van der Pol, et al.
Gene Therapy|February 17, 2006
Melanoma cultures show different susceptibility towards E1A-, E1B-19 kDa- and fiber-modified replication-competent adenovirusesM Schmitz, C Graf, T Gut, et al.
Psychophysiology|April 11, 2019
Baseline resting heart rate variability predicts post-traumatic stress disorder treatment outcomes in adults with co-occurring substance use disorders and post-traumatic stressHeather E Soder, Margaret C Wardle, Joy M Schmitz, et al.
Journal of Surgical Education|January 10, 2026
Mapping the Surgical Personality: A Scoping Review of Personality Traits in Surgical Education and Career ChoiceSophia M Schmitz, Amila Dedovic, Laura Mazilescu, et al.
Psychophysiology|January 18, 2024
A meta-analysis of electrophysiological biomarkers of reward and error monitoring in substance misuseHeather E Webber, Constanza de Dios, Danielle A Kessler, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 25, 1999
Negative chronotropic effects of fentanyl attenuate beneficial effects of dobutamine on oxygen metabolism: hemodynamic and pharmacokinetic interactionsG J Locker, R M Mader, B Rizovski, et al.
Anticancer Research|May 25, 2004
Monitoring of serum Her-2/neu predicts histopathological response to neoadjuvant trastuzumab-based therapy for breast cancerWolfgang J Köstler, Günther G Steger, Afschin Soleiman, et al.
Pageof 93